Indeed, consistent with this hypothesis, Bonnet et al.57 recently demonstrated that transgenic mice overexpressing RANKL have systemic insulin resistance and reduced glucose uptake in non-skeletal tissues (muscle, brain), but increased glucose update in bone (femur). This evidence concerns the gene TNFSF11 and Insulin resistance.